近视治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00016387
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 206
Buy Now

[研究报告]市场价值预计将从2022年的102.7667亿美元增长到2030年的195.7185亿美元。进一步预计近视治疗市场2022年至2030年的复合年增长率将达到8.39%。
市场洞察分析师观点:
近视,也称为近视,是一种常见的眼部疾病,人们可以清楚地看到近处的物体,但远处的物体却显得模糊。当眼球拉长或角膜过于弯曲时,就会发生这种情况,导致光线聚焦在视网膜前面,而不是直接聚焦在视网膜上。近视可以遗传,通常在儿童期或青春期发生,但也可能发生在成人身上。用于治疗近视的一种措施是矫正镜片,例如框架眼镜或隐形眼镜,它们有助于将光线直接聚焦在视网膜上。另一种措施是屈光手术,例如 LASIK 或 PRK,它可以重塑角膜以改善视力。同样,角膜塑形术可在夜间佩戴的特殊隐形眼镜的帮助下暂时重塑角膜并减少白天的近视。
增长驱动因素和限制:
全球近视患病率的上升是一个重大的公共卫生问题,特别是在儿童和年轻人中观察到发病率不断增加。最近的一项研究估计,到 2050 年,世界上近 50% 的人口(即 50 亿人)将患有近视,高于目前 30% 的平均水平。东亚和东南亚是近视热点地区,韩国、台湾、新加坡、中国和日本等国家有 80-90% 的人患有近视。在美国,近视发生率也在增加;据报道,这一比例为 42%,在短短 30 年内几乎翻了一番。多种因素促成了这一趋势,包括生活方式的改变、城市化进程的加快以及大量的近距离工作活动,例如长时间使用数字设备和有限的户外活动。虽然遗传倾向发挥着一定作用,但环境因素也会导致近视率大幅上升。这些生活方式和环境因素的影响使人们更加了解遗传易感性和环境影响之间复杂的相互作用,进一步强调需要采取全面的战略来解决这一新兴的公共卫生问题。据《自然》杂志报道,欧洲近视患者比例从 2012 年的 10% 增加到 2016 年的约 25%,到 2023 年将达到 40% 以上,年轻群体中近视患者比例将超过 50%。随着近视患病率持续上升,人们越来越重视制定积极的干预措施、公共卫生运动和创新治疗方法,以减轻高度近视及其相关眼部并发症的长期影响,从而强调解决这一问题的重要性多方面的全球健康挑战。
另一方面,由于缺乏专门从事近视管理的熟练眼保健专业人员,近视治疗市场面临着严峻的挑战。随着近视影响全球数百万人,对接受过近视控制和管理培训的熟练验光师和眼科医生的需求激增。然而,缺乏能够有效实施和监测近视治疗计划(例如角膜塑形术和阿托品治疗)的专业人士,阻碍了这些渐进式治疗方法的广泛采用。由于近视患病率不断上升,特别是在年轻人中,这种短缺现象更加严重,因此需要采取积极主动、全面的近视管理方法。解决这一不足的努力需要扩大教育和培训计划,使眼保健专业人员具备提供以近视为重点的护理所需的技能。这确保了市场能够有效满足不断增长的近视治疗需求,并有助于改善视力健康结果。
趋势:
人工智能(AI)越来越多地应用于近视治疗。一个例子是使用人工智能设备来监测和分析眼球运动和视力,这可以帮助识别近视的早期迹象并跟踪其进展情况。人工智能算法还可用于根据患者的特征和病史制定个性化的治疗计划。未来,人工智能有望在近视治疗中发挥更大作用。例如,研究人员正在探索使用机器学习算法来预测近视高危儿童,以便进行早期干预和预防。
此外,人工智能驱动的虚拟现实系统可以提高视力并减少近视进展。因此,近视治疗市场预计在未来几年将持续增长和创新。随着全球近视患病率的不断上升,对有效且易于使用的治疗方法的需求日益增长。人工智能和先进手术技术等技术进步预计将推动这一增长,并带来更加个性化和有效的近视治疗。此外,可能会更加关注预防措施以及行业和学术界之间的合作,以解决这一全球健康问题。
战略见解
报告细分和范围:
近视治疗市场的细分依据类型、治疗、年龄组和最终用户。根据类型,市场分为高度近视、退行性近视和渐进性近视。在治疗方面,市场分为低剂量阿托品滴眼液、屈光手术、隐形眼镜和ortho-K。近视治疗市场按年龄层分为成人近视和儿童近视。就最终用户而言,近视治疗市场分为医院和诊所、专科诊所和屈光手术中心。从地域来看,近视治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国) 、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷、以及南美洲和中美洲其他地区)。
细分分析:
近视治疗市场根据类型分为高度近视、退行性近视和进行性近视。到2022年,高度近视细分市场在近视治疗市场中占据最大份额。高度近视也称为病理性或退行性近视,代表近视的一种高级形式,其特征是眼球明显拉长和眼部并发症风险增加。高度近视患者通常会出现严重的视力障碍,并且容易出现一系列威胁视力的疾病,包括视网膜脱离、近视性黄斑病变、青光眼和脉络膜新生血管形成。这种情况通常在儿童期和青春期发展,可显着影响个人的生活质量,使阅读和驾驶更具挑战性。
近视治疗市场,按类型 - 2022 年和 2030 年
近视治疗市场,基于治疗、细分为低剂量阿托品滴眼液、屈光手术、隐形眼镜和ortho-k。 2022年,低剂量阿托品滴眼液在近视治疗市场中占据最大份额。低剂量阿托品滴眼液是一种很有前景的近视治疗方法,特别是对于儿童和青少年而言。近视,通常称为近视,是一种常见的屈光缺陷,导致远处物体的图像模糊。阿托品是一种通过降低眼睛聚焦肌和扩张瞳孔来帮助减缓近视进展的药物。
按年龄组划分,近视治疗市场分为成人近视和儿童近视。 2022年,成人近视细分市场在近视治疗市场中占据较大份额。成人近视的特点是看不清远处的物体,通常需要矫正镜片才能获得清晰的视力。成年后近视的发生和发展会影响日常生活的各个方面,从阅读和电脑工作到驾驶和参加户外活动。除了依赖矫正措施带来的不便之外,成人近视还可能导致长期的眼部健康问题,包括增加患近视黄斑病、白内障和青光眼的风险。
就最终用户而言,近视治疗市场分为进入医院和诊所、专科诊所和屈光手术中心。 2022年,医院和诊所在近视治疗市场中占据最大份额。医院和诊所是提供各种疾病和健康状况治疗的初级医疗机构。医院提供初级保健,提供最好的设施和患者服务。多专科医院和诊所针对各种眼部疾病提供多种治疗方法;医院的眼科医生治疗了数千名患有各种眼部疾病的患者。由于拥有最好的医生和协助人员,治疗很容易在医院进行。
区域分析:
近视治疗市场根据区域划分为北美、欧洲、亚太地区、南美和南美地区。中美洲、中东和非洲。 2022年,北美在全球近视治疗市场中占据最大份额,预计亚太地区市场在2022年至2030年期间复合年增长率最高。
美国近视治疗市场预计在未来将出现显着增长年。近年来,近视患病率不断增加,这推动了对有效治疗的需求。根据近视研究所 2023 年发布的数据,美国的患病率为 42%,在短短三十年里几乎翻了一番。此外,人们对近视的认识不断提高也推动了市场增长。例如,布莱恩·霍尔顿视力研究所 (Brien Holden Vision Institute) 的 2024 年近视意识周选择了《近视管理回顾》(Review of Myopia Management) 作为其官方联合赞助商。此次合作将有助于扩大近视宣传周的影响范围,该活动定于 2024 年 5 月 13 日至 19 日在国内和国际层面举行。越来越多的人开始意识到与近视相关的风险,例如患上其他眼睛的风险增加病症——白内障和青光眼。这导致对有助于预防或减缓近视进展的有效治疗的需求更大。推动美国近视治疗市场增长的另一个因素是先进技术和治疗方法的可用性。现在有多种近视治疗方法,包括矫正镜片、角膜塑形术和药物治疗。这些治疗方法变得越来越复杂和有效,有助于推动近视治疗的需求。最后,儿童近视患病率的不断上升正在推动美国近视治疗市场的增长。随着越来越多的儿童被诊断出患有近视,更加需要有效的治疗方法来帮助预防或减缓其进展。这导致了对专门为儿童设计的新疗法的研究和开发的投资增加。总体而言,随着越来越多的人意识到近视的状况和对有效治疗的需求,美国近视治疗市场预计在未来几年将增长。
行业发展和未来机遇:
全球近视领域知名企业的不同举措治疗市场如下:
2023年10月,NIDEK CO LTD推出了NP-1/NP-1C预装人工晶状体注射系统。 NP-1/NP-1C 是一款完全预载的注射系统,配有非球面疏水性软丙烯酸镜片,旨在实现更顺畅、更安全、可靠的 IOL 植入。这种新开发的注射器专为平稳、受控的输送而设计。 NP-1/NP-1C 可以通过简单的两步过程(包括填充粘弹性材料和按压柱塞)实现快速、轻松的操作。2023 年 8 月,CooperVision MiSight 1 日间隐形眼镜现已获得国家批准在中国使用。药品监督管理局(NMPA)负责监管药品和医疗器械。这一批准是在经过彻底的审查过程之后获得的。凭借这一新进展,这款创意软性隐形眼镜成为中国首个推荐的可减少眼轴延长过程的产品。2023年8月,卡尔蔡司股份公司宣布在印度班加罗尔合作开设首家近视中心与 SR Gopal Rao 的近视中心合作。该中心将提供专业服务,包括全面的眼科检查、先进的成像技术、个性化的近视管理计划以及各种定制眼镜架。新中心的启动将减缓近视发展,使公司及其利益相关者受益。竞争格局和主要公司:
Haag-Streit Holding (Metall Zug)、2EyesVision、Ziemer Group、NIDEK CO., LTD、Alcon、Carl Zeiss AG、CooperVision、Bausch Health、Johnson & Johnson Vision (Johnson & Johnson) 和 Topcon Healthcare Inc 是近视治疗市场的知名参与者。这些公司专注于新技术的开发和采用、现有产品的进步以及扩大其地域分布,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Myopia?

Myopia, also known as nearsightedness, is a common eye condition where a person can see objects close to them clearly but objects far away appear blurry. This happens when the eyeball is too long or the cornea is too curved, causing light to focus in front of the retina instead of directly on it. Myopia can be inherited and usually develops during childhood or adolescence, but it can also occur in adults.

What factors drive the myopia treatment market?

Key factors driving the market growth are rising prevalence of myopia, and increased awareness of myopia treatment. However, lack of skilled professionals hinders the myopia treatment market growth.

Who are the major players in the myopia treatment market?

The myopia treatment market majorly consists of the players, including Haag-Streit Holding (Metall Zug), 2EyesVision, Ziemer Group, NIDEK CO., LTD, Alcon, Carl Zeiss AG, CooperVision, Bausch Health, Johnson & Johnson Vision (Johnson & Johnson), and Topcon Healthcare Inc.

What was the estimated myopia treatment market size in 2022?

The myopia treatment market was valued at US$ 10,276.67 million in 2022.

What are the growth estimates for the myopia treatment market till 2030?

The myopia treatment market is expected to be valued at US$ 19,571.85 million in 2030.

Which type segment dominates the myopia treatment market?

The myopia treatment market, based on type, is segmented into high myopia, degenerative myopia and progressive myopia. The high myopia segment held the largest share in the myopia treatment market in 2022. High myopia, also known as pathological or degenerative myopia, represents an advanced form of nearsightedness characterized by a significantly elongated eyeball and an increased risk of ocular complications.

Which treatment segment dominates the myopia treatment market?

The myopia treatment market, based on treatment, is segmented into low dose atropine eye drops, refractive surgery, contact lenses, and ortho-k. The low-dose atropine eye drops segment held the largest share in the myopia treatment market in 2022. Low-dose atropine eye drops are a promising treatment for myopia, particularly in children and adolescents.

Which age group segment dominates the myopia treatment market?

By age group, myopia treatment market segmented into adult myopia and childhood myopia. The adult myopia segment held the largest share in the myopia treatment market in 2022. Adult myopia, characterized by difficulty seeing objects at a distance, often requires corrective lenses for clear vision.

Which end user segment dominates the myopia treatment market?

On the basis of end user, Myopia treatment market is classified into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest share in the myopia treatment market in 2022.

The List of Companies - Myopia Treatment Market 

  1. Haag-Streit Holding (Metall Zug)
  2. 2EyesVision
  3. Ziemer Group
  4. NIDEK CO., LTD
  5. Alcon
  6. Carl Zeiss AG
  7. CooperVision
  8. Bausch Health
  9. Johnson & Johnson Vision (Johnson & Johnson)
  10. Topcon Healthcare Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports